Filing Flows › Regenerative Medical Technology Group (RMTG) › Q1 2026
Regenerative Medical Technology Group (RMTG) Q1 2026 earnings results (first quarter 2026)
10-Q filed Jun 9, 2026
Regenerative Medical Technology Group (RMTG) reported revenue of $2.6M for the first quarter 2026 (Q1 2026), +93% from a year earlier and +68% from the quarter before. Operating margin was 8.7%, net loss $876K (33.2% of revenue).
Regenerative Medical Technology Group, Q1 2026: revenue $2.6M (+94% year over year), operating margin 8.7%, net loss $876K, operating cash flow $102K. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.6M | +68% | +93% |
| Operating profit | $230K | — | +70% |
| Net earnings | −$876K | — | — |
| Operating cash flow | $102K | +167% | +79% |
What changed
Revenue was $2.6M in Q1 2026, up 93% year over year and up 68% from the previous quarter. Product Supplies was the largest line at 48% of revenue. Product Supplies added $640K year over year (up 102%), 50% of the total change.
Gross margin was 66.9%, down 2.3 points from Q1 2025. Operating profit was $230K, a 8.7% margin (down 1.2 points year over year). Of the extra revenue versus Q1 2025, 7% reached operating profit, below the 10% margin then. Operating expenses grew 90% against revenue growth of 93%. The fastest-growing cost line was Sales & marketing (+149%). The quarter ended with a net loss of $876K, narrower than the previous quarter's $1.4M loss. Net interest and other expense of $1.1M was the main reason.
Operating cash flow was $102K (up 79% year over year). Non-cash charges added back $98K of depreciation and amortization. Working capital and other items added $881K. Capital expenditures of $315K exceeded it, leaving free cash flow of −$213K.
Questions
What was Regenerative Medical Technology Group's revenue in the first quarter 2026?
Regenerative Medical Technology Group (RMTG) reported revenue of $2.6M for the first quarter 2026 (Q1 2026), +93% from a year earlier and +68% from the quarter before.
Was Regenerative Medical Technology Group profitable in the first quarter 2026?
Operating profit was $230K (8.7% of revenue) and net loss $876K.
Source: Regenerative Medical Technology Group 10-Q on SEC EDGAR.